Clinical Trial Update: Topical Imiquimod Treatment of Oral Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating topical imiquimod for treating oral dysplasia and oral leukoplakia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Dysplasia
• Oral Leukoplakia

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: University of Southern California | Conditions: Oral Dysplasia, Leukoplakia Oral | Phase 1, Phase 2 | Status: RECRUITING